We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Pericarditis during infliximab therapy in paediatric ulcerative colitis.
- Authors
Dipasquale, V.; Gramaglia, S. M. C.; Catena, M. A.; Romano, C.
- Abstract
What is known and study objective Infliximab is a widely used drug for treating inflammatory bowel disease ( IBD). This drug is known to rarely cause pericarditis in adult populations. Case summary This report details the case of a 14-year-old boy with ulcerative colitis who developed pericarditis after a second infliximab infusion. After discontinuation of therapy, the patient's symptoms were resolved. What is new and conclusion To our knowledge, this is the first reported paediatric case of pericarditis as a possible complication of infliximab therapy in IBD. Among infliximab-related delayed adverse reactions, cardiac complications should be monitored in the paediatric population.
- Subjects
ITALY; DRUG side effects; PERICARDITIS; THERAPEUTIC complications; ULCERATIVE colitis; INFLIXIMAB; ADOLESCENCE
- Publication
Journal of Clinical Pharmacy & Therapeutics, 2018, Vol 43, Issue 1, p107
- ISSN
0269-4727
- Publication type
Article
- DOI
10.1111/jcpt.12586